Carrot Anthocyanins Genetics and Genomics: Standing and Views to Enhance Its Software for the Meals Colorant Trade
Purple or black carrots (Daucus carota ssp. sativus var. atrorubens Alef) are characterised by their darkish purple- to black-colored roots, owing their look to excessive anthocyanin concentrations.
In recent times, there was rising curiosity in using black carrot anthocyanins as pure meals dyes. Black carrot roots include giant portions of mono-acylated anthocyanins, which impart a measure of heat-, light- and pH-stability, enhancing the color-stability of meals merchandise over their shelf-life.
The genetic pathway controlling anthocyanin biosynthesis seems properly conserved amongst land vegetation; nevertheless, totally different variants of anthocyanin-related genes between cultivars leads to tissue-specific accumulations of purple pigments.
Thus, broad genetic variations of anthocyanin profile, and tissue-specific distributions in carrot tissues and organs, could be noticed, and the ratio of acylated to non-acylated anthocyanins varies considerably within the purple carrot germplasm.
Moreover, anthocyanins synthesis can be influenced by a variety of exterior elements, equivalent to abiotic stressors and/or chemical elicitors, straight affecting the anthocyanin yield and stability potential in meals and beverage functions.
On this examine, we critically evaluation and talk about the present information on anthocyanin range, genetics and the molecular mechanisms controlling anthocyanin accumulation in carrots. We additionally present a view of the present information gaps and development wants as regards growing and making use ofrevolutionary molecular instruments to enhance the yield, product efficiency and stability of carrot anthocyanin to be used as a pure meals colorant.
Anti-IL-8 antibody |
|||
| STJ97710 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Mouse monoclonal to IL-8. |
|||
Anti-IL-8 antibody |
|||
| STJ97717 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Mouse monoclonal to IL-8. |
|||
Anti-IL-8 antibody |
|||
| STJ97720 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Mouse monoclonal to IL-8. |
|||
Anti-IL-8 antibody |
|||
| STJ98175 | St John's Laboratory | 100 µl | EUR 280.8 |
|
Description: Mouse monoclonal to IL-8. |
|||
anti-IL-8 (3E4D8) |
|||
| LF-MA30011 | Abfrontier | 100 ul | EUR 448.8 |
|
Description: Mouse Monoclonal to IL-8 |
|||
mAb mouse anti-human IL-8 |
|||
| CT264 | U-CyTech | 0.5 mg | EUR 312 |
IL-8/CXCL8, Human |
|||
| HY-P7224 | MedChemExpress | 50ug | EUR 596.4 |
Human IL-8 Protein |
|||
| abx060803-25ug | Abbexa | 25 ug | EUR 644.4 |
Human IL-8 Protein |
|||
| abx060804-25ug | Abbexa | 25 ug | EUR 644.4 |
Recombinant Human IL-8 |
|||
| P0180 | FN Test | 100ug | EUR 626.83 |
|
Description: Recombinant Human protein for IL-8 |
|||
Recombinant Human IL-8 |
|||
| SJB05-01 | Amyotop | 25µg/vial | EUR 342 |
Anti-IL-8 Monoclonal Antibody |
|||
| A00423-1 | BosterBio | 100ul | EUR 476.4 |
|
Description: Mouse Monoclonal Antibody for IL-8 Antibody (CXCL8) detection. Tested with IHC in Human, Mouse, Rat. |
|||
Human Interleukin-8 (IL-8) Antibody (Biotin Conjugate) |
|||
| 13102-05021 | AssayPro | 150 ug | EUR 313.2 |
Human IL-8 ELISA antibody pair |
|||
| CT748-10 | U-CyTech | 10-plate | EUR 656.4 |
Human IL-8 ELISA antibody pair |
|||
| CT748-20 | U-CyTech | 20-plate | EUR 1118.4 |
Human IL-8 Antibody (Biotin Conjugate) |
|||
| 33486-05121 | AssayPro | 150 ug | EUR 442.8 |
Human Interleukin 8 (IL-8) CLIA Kit |
|||
| abx195916-96tests | Abbexa | 96 tests | EUR 990 |
Human Interleukin 8,IL-8 ELISA KIT |
|||
| 201-12-0090 | SunredBio | 96 tests | EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
Human Interleukin 8, IL-8 ELISA KIT |
|||
| CSB-E04641h-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
|
Description: Quantitative sandwich ELISA kit for measuring Human Interleukin 8, IL-8 in samples from serum, cell culture supernates, saliva, urine, cerebrospinalfluid (CSF), tissue homogenates, cell lysates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Human Interleukin 8, IL-8 ELISA KIT |
|||
| 1-CSB-E04641h | Cusabio |
|
|
|
Description: Quantitative sandwich ELISA kit for measuring Human Interleukin 8, IL-8 in samples from serum, cell culture supernates, saliva, urine, cerebrospinalfluid(CSF), tissue homogenates, cell lysates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
Human Interleukin 8(IL-8)ELISA Kit |
|||
| GA-E0129HM-48T | GenAsia Biotech | 48T | EUR 346.8 |
Human Interleukin 8(IL-8)ELISA Kit |
|||
| GA-E0129HM-96T | GenAsia Biotech | 96T | EUR 559.2 |
Human IL-8(Interleukin 8) ELISA Kit |
|||
| EH0205 | FN Test | 96T | EUR 571.5 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 18.75pg/ml |
|||
Human Interleukin 8(IL-8)ELISA Kit |
|||
| QY-E04259 | Qayee Biotechnology | 96T | EUR 433.2 |
Human Interleukin 8,IL-8 ELISA KIT |
|||
| YLA1210HU-48T | Shanghai YL Biotech | 48T | EUR 435 |
Human Interleukin 8,IL-8 ELISA KIT |
|||
| YLA1210HU-96T | Shanghai YL Biotech | 96T | EUR 562.5 |
Human Interleukin-8 (IL-8) ELISA Kit |
|||
| LF-EK60006 | Abfrontier | 1×96T | EUR 948 |
human IL-8 His tag |
|||
| E410A07-100 | EnoGene | 100μg | EUR 1152 |
Human IL-8 ELISA kit |
|||
| CT212A | U-CyTech | 5-plate | EUR 554.4 |
Human IL-8 ELISA kit |
|||
| LF-EK50165 | Abfrontier | 1×96T | EUR 777.6 |
IL-8 ELISA KIT|Human |
|||
| EF003990 | Lifescience Market | 96 Tests | EUR 826.8 |
Human IL-8 ELISA Kit |
|||
| EHI0063 | Abclonal | 96Tests | EUR 625.2 |
IL-8/CXCL8, 72a.a., Human |
|||
| HY-P7380 | MedChemExpress | 50ug | EUR 596.4 |
IL-8 (Human) ELISA Kit |
|||
| K4169-100 | Biovision | each | EUR 874.8 |
Human Interleukin-8 (IL-8) AssayLite Antibody (RPE Conjugate) |
|||
| 13102-05051 | AssayPro | 150 ug | EUR 513.6 |
Human Interleukin-8 (IL-8) AssayLite Antibody (APC Conjugate) |
|||
| 13102-05061 | AssayPro | 150 ug | EUR 513.6 |
Human Interleukin-8 (IL-8) AssayLite Antibody (FITC Conjugate) |
|||
| 13102-05041 | AssayPro | 150 ug | EUR 513.6 |
Human Interleukin-8 (IL-8) AssayLite Antibody (PerCP Conjugate) |
|||
| 13102-05071 | AssayPro | 150 ug | EUR 565.2 |
rec Monocyte IL-8 (human) |
|||
| H-9625.0005 | Bachem | 5.0µg | EUR 194.4 |
|
Description: Sum Formula: C372H600N106O106S4; CAS# [142298-00-8] |
|||
rec Monocyte IL-8 (human) |
|||
| H-9625.0025 | Bachem | 25.0µg | EUR 457.2 |
|
Description: Sum Formula: C372H600N106O106S4; CAS# [142298-00-8] |
|||
rec Endothelial IL-8 (human) |
|||
| H-3742.0010 | Bachem | 10.0µg | EUR 340.8 |
|
Description: Sum Formula: C397H644N114O111S4; CAS# [142298-01-9] |
|||
rec Endothelial IL-8 (human) |
|||
| H-3742.0050 | Bachem | 50.0µg | EUR 1167.6 |
|
Description: Sum Formula: C397H644N114O111S4; CAS# [142298-01-9] |
|||
Recombinant Human IL-8 (72a.a.) |
|||
| HEILP-0801 | Cyagen | 5ug | Ask for price |
Recombinant Human IL-8 (77a.a.) |
|||
| HEILP-0802 | Cyagen | 5ug | Ask for price |
Recombinant Human IL-8 Protein |
|||
| RP00052 | Abclonal | 5 μg | EUR 178.8 |
Human IL-8 Recombinant Protein |
|||
| R00423-8 | BosterBio | 5ug/vial | EUR 310.8 |
|
Description: Interleukin-8 (IL-8), also known as CXCL8, is an ELR-positive CXC family member chemokine produced by macrophages and other cell types such as epithelial cells. ELR-positive CXC chemokines such as IL-8 specifically induce the migration of neutrophils, and interact with chemokine receptors CXCR1 and CXCR2. Human IL-8 Recombinant Protein is purified interleukin-8 produced in yeast. |
|||
Anti-bovine IL-8 (CXCL8) antibody |
|||
| STJ15100008 | St John's Laboratory | 250 µg | EUR 403.2 |
|
Description: These monoclonal antibodies enable sensitive and specific detection of bovine IL-8 in ELISpot. |
|||
Anti-bovine IL-8 (CXCL8) antibody |
|||
| STJ15100009 | St John's Laboratory | 250 µg | EUR 403.2 |
|
Description: This monoclonal antibody enables sensitive and specific detection of bovine IL-8 in ELISA. |
|||
CLIA kit for Human IL-8 (Interleukin 8) |
|||
| E-CL-H0048 | Elabscience Biotech | 1 plate of 96 wells | EUR 700.8 |
|
Description: A sandwich CLIA kit for quantitative measurement of Human IL-8 (Interleukin 8) in samples from Serum, Plasma, Cell supernatant |
|||
IL-8, CXCL8, Interleukin-8 (72 a.a.), human |
|||
| RC212-19A | Bio Basic | 5ug | EUR 125.26 |
IL-8, CXCL8, Interleukin-8 (77 a.a.), human |
|||
| RC212-19B | Bio Basic | 5ug | EUR 125.26 |
IL-8 Antibody |
|||
| BF0238 | Affbiotech | 200ul | EUR 540 |
IL-8 Antibody |
|||
| 5149-100 | Biovision | each | EUR 405.6 |
IL-8 Antibody |
|||
| F51235-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
|
Description: IL8 is a member of the CXC chemokine family. This chemokine is one of the major mediators of the inflammatory response. This chemokine is secreted by several cell types. It functions as a chemoattractant, and is also a potent angiogenic factor. |
|||
IL-8 Antibody |
|||
| F51235-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
|
Description: IL8 is a member of the CXC chemokine family. This chemokine is one of the major mediators of the inflammatory response. This chemokine is secreted by several cell types. It functions as a chemoattractant, and is also a potent angiogenic factor. |
|||
IL-8 Antibody |
|||
| R30420 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: Interleukin-8(IL-8) is a chemokine produced by macrophages and other cell types such as epithelial cells. It is also synthesized by endothelial cells, which store IL-8 in their storage vesicles, the Weibel-Palade bodies. In humans, the interleukin-8 protein is encoded by the IL8 gene. Interleukin-8(IL8) is a member of the CXC chemokine family(Hull et al., 2001). IL-8 is believed to play a role in the pathogenesis of bronchiolitis, a common respiratory tract disease caused by viral infection. This gene and other ten members of the CXC chemokine gene family form a chemokine gene cluster in a region mapped to chromosome 4q. The genes for IL8 have been co-localized on a 335-kb genomic fragment. |
|||
IL-8 Antibody |
|||
| R31932 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: Interleukin-8 (IL-8) is a chemokine produced by macrophages and other cell types such as epithelial cells. It is also synthesized by endothelial cells, which store IL-8 in their storage vesicles, the Weibel-Palade bodies. In humans, the interleukin-8 protein is encoded by the IL8 gene. Interleukin-8 (IL8) is a member of the CXC chemokine family. IL-8 is believed to play a role in the pathogenesis of bronchiolitis, a common respiratory tract disease caused by viral infection. This gene and other ten members of the CXC chemokine gene family form a chemokine gene cluster in a region mapped to chromosome 4q. The genes for IL8 have been co-localized on a 335-kb genomic fragment. |
|||
ELISA kit for Human IL-8 (Interleukin 8) |
|||
| E-EL-H0048 | Elabscience Biotech | 1 plate of 96 wells | EUR 452.4 |
|
Description: A sandwich ELISA kit for quantitative measurement of Human IL-8 (Interleukin 8) in samples from Serum, Plasma, Cell supernatant |
|||
ELISA kit for Human Interleukin 8,IL-8 |
|||
| EK0240 | SAB | 96 tests | EUR 723.6 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human Interleukin 8,IL-8 in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
Human Interleukin-8 (IL-8) AssayMax ELISA Kit |
|||
| EI1008-1 | AssayPro | 96 Well Plate | EUR 572.4 |
Human IL-8 AssayLite Antibody (RPE Conjugate) |
|||
| 33486-05151 | AssayPro | 150 ug | EUR 513.6 |
Human IL-8 AssayLite Antibody (APC Conjugate) |
|||
| 33486-05161 | AssayPro | 150 ug | EUR 513.6 |
Recombinant Human Interleukin-8/IL-8 (C-6His) |
|||
| CC97-10ug | Novoprotein | 10ug | EUR 175.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (C-6His) |
|||
| CC97-1mg | Novoprotein | 1mg | EUR 2739.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (C-6His) |
|||
| CC97-500ug | Novoprotein | 500ug | EUR 1935.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (C-6His) |
|||
| CC97-50ug | Novoprotein | 50ug | EUR 406.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Human IL-8 AssayLite Antibody (FITC Conjugate) |
|||
| 70021-05141 | AssayPro | 150 ug | EUR 513.6 |
Human IL-8 AssayLite Antibody (FITC Conjugate) |
|||
| 33486-05141 | AssayPro | 150 ug | EUR 513.6 |
Human IL-8 AssayLite Antibody (PerCP Conjugate) |
|||
| 33486-05171 | AssayPro | 150 ug | EUR 565.2 |
Recombinant Human Interleukin-8/IL-8 (Ser28-Ser99) |
|||
| C035-10ug | Novoprotein | 10ug | EUR 181.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (Ser28-Ser99) |
|||
| C035-1mg | Novoprotein | 1mg | EUR 2203.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (Ser28-Ser99) |
|||
| C035-500ug | Novoprotein | 500ug | EUR 1557.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (Ser28-Ser99) |
|||
| C035-50ug | Novoprotein | 50ug | EUR 424.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (Ala23-Ser99) |
|||
| C037-10ug | Novoprotein | 10ug | EUR 181.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (Ala23-Ser99) |
|||
| C037-1mg | Novoprotein | 1mg | EUR 2203.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (Ala23-Ser99) |
|||
| C037-500ug | Novoprotein | 500ug | EUR 1557.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (Ala23-Ser99) |
|||
| C037-50ug | Novoprotein | 50ug | EUR 412.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
IL-8 |
|||
| E5-00004 | EnoGene | 1mg | EUR 1152 |
ELISA kit for Human IL-8 |
|||
| KET6018-48T | Abbkine | 48T | EUR 242.4 |
|
Description: Quantitative sandwich ELISA for measuring Human IL-8 in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human IL-8 |
|||
| KET6018-5platesof96wells | Abbkine | 5 plates of 96 wells | EUR 1292.4 |
|
Description: Quantitative sandwich ELISA for measuring Human IL-8 in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human IL-8 |
|||
| KET6018-96T | Abbkine | 96T | EUR 346.8 |
|
Description: Quantitative sandwich ELISA for measuring Human IL-8 in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
Human IL-8 ELISA kit (4X96T) |
|||
| LF-EK50166 | Abfrontier | 4×96T | EUR 2641.2 |
Human IL-8/CXCL8 ELISA Kit |
|||
| RK00011 | Abclonal | 96 Tests | EUR 625.2 |
IL-8 (77 a.a.), human recombinant |
|||
| 4149-1000 | Biovision | each | EUR 4758 |
Characterization of Anti-Inflammatory and Antioxidant Constituents from Scutellaria baicalensis Utilizing LC-MS Coupled with a Bioassay Technique
An efficient and beforehand demonstrated screening technique for energetic constituents in pure <em>merchandise</em> utilizing LC-MS coupled with a bioassay was reported in our earlier research.
With this, the present investigation tried to determine bioactive constituents of <i>Scutellaria baicalensis</i> via LC-MS coupled with a bioassay.
Peaks at broadly 17-20 and 24-25 min on the MS chromatogram displayed an inhibitory impact on NO manufacturing in lipopolysaccharide-induced BV2 microglia cells.
Equally, peaks at roughly 17-19 and 22 min confirmed antioxidant exercise with an 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS)/2,2-diphenyl-1- picrylhydrazyl (DPPH) assay.
For affirmation of LC-MS coupled with a bioassay, 9 compounds (<b>1</b>-<b>9</b>) have been remoted from an MeOH extract of <i>S. baicalensis</i>. As we predicted, compounds <b>1</b>, <b>8</b>, and <b>9</b> considerably lowered lipopolysaccharide (LPS)-induced NO manufacturing in BV2 cells.
Likewise, compounds <b>5</b>, <b>6</b>, and <b>8</b> exhibited free radical-scavenging actions with the ABTS/DPPH assay. As well as, the structural similarity of the principle elements was confirmed by analyzing the whole extract and EtOAc fractions via <em>molecular</em> networking.
Total, the outcomes recommend that the strategy comprised of LC-MS coupled with a bioassay can successfully predict energetic compounds with out an isolation course of, and the outcomes of <em>molecular</em> networking predicted that different elements across the energetic compound node can also be energetic.
Polymer-Derived Heteroatom-Doped Porous Carbon Supplies
Heteroatom-doped porous carbon supplies (HPCMs) have discovered in depth functions in adsorption/separation, natural catalysis, sensing, and power conversion/storage.
The even handed alternative of carbon precursors is essential for the manufacture of HPCMs with particular usages and maximization of their capabilities. On this regard, polymers as precursors have demonstrated nice promise due to their versatile molecular and nanoscale constructions, modulatable chemical composition, and wealthy processing strategies to generate textures that, together with correct solid-state chemistry, could be maintained all through carbonization.
This Overview comprehensively surveys the progress in polymer-derived practical HPCMs by way of the right way to produce and management their porosities, heteroatom doping results, and morphologies and their associated use.
First, we summarize and talk about artificial approaches, together with laborious and delicate templating strategies in addition to direct synthesis methods using polymers to manage the pores and/or heteroatoms in HPCMs. Second, we summarize the heteroatom doping results on the thermal stability, digital and optical properties, and floor chemistry of HPCMs.
Particularly, the heteroatom doping impact, which includes each single-type heteroatom doping and codoping of two or extra kinds of heteroatoms into the carbon community, is mentioned.
Contemplating the significance of the morphologies of HPCMs of their utility spectrum, potential decisions of appropriate polymeric precursors and methods to exactly regulate the morphologies of HPCMs are offered.
Lastly, we present our perspective on the right way to predefine the constructions of HPCMs through the use of polymers to comprehend their potential functions within the present fields of power era/conversion and environmental remediation.
We imagine that these analyses and deductions are helpful for a systematic understanding of polymer-derived carbon supplies and can function a supply of inspiration for the design of future HPCMs.
Mouse FLT-4/VEGFR-3 Control/blocking peptide #1 |
|||
| FLT41-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
VEGFR-1/Flt1/ Rat VEGFR- 1/ Flt1 ELISA Kit |
|||
| ELA-E0147r | Lifescience Market | 96 Tests | EUR 1063.2 |
Rabbit Anti-Human FLT-4/VEGFR-3 IgG #2, aff pure |
|||
| FLT42-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Human FLT-4/VEGFR-3 control/blocking peptide #2 |
|||
| FLT42-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Human VEGFR-1/Flt1 ELISA Kit |
|||
| EHV0045 | Abclonal | 96Tests | EUR 625.2 |
Recombinant human VEGFR1/Flt-1 Protein |
|||
| RP01188 | Abclonal | 5 μg | EUR 163.2 |
Anti-VEGFR-1/FLT-1 antibody |
|||
| PAab09393 | Lifescience Market | 100 ug | EUR 426 |
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNCA0658-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), APC conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNCA0659-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), APC conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC800658-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF680 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC800658-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF680 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC800659-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF680 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC800659-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF680 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC810658-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF680R conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC810658-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF680R conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC810659-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF680R conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC810659-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF680R conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC940658-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF594 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC940658-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF594 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC940659-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF594 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC940659-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF594 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC700658-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF770 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC700658-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF770 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC700659-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF770 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC700659-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF770 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC880658-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF488A conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC880658-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF488A conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC880659-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF488A conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC880659-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF488A conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC040658-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF405S conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC040658-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF405S conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC040659-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF405S conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC040659-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF405S conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC400658-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF640R conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC400658-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF640R conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC400659-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF640R conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC400659-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF640R conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC050658-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF405M conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC050658-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF405M conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC050659-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF405M conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC050659-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF405M conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNCB0658-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), Biotin conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNCB0658-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), Biotin conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNCB0659-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), Biotin conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNCB0659-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), Biotin conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNCAP0658-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNCAP0658-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNCAP0659-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNCAP0659-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNCR0658-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), RPE conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNCR0659-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), RPE conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNCP0658-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), PerCP conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNCP0659-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), PerCP conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNUM0658-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), 1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNUM0659-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), 1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNCH0658-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNCH0658-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNCH0659-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNCH0659-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNUB0658-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), Concentration: 0.2mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNUB0658-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), Concentration: 0.2mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNUB0659-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), Concentration: 0.2mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNUB0659-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), Concentration: 0.2mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC550658-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF555 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC550658-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF555 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC550659-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF555 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC550659-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF555 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC610658-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF660R conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC610658-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF660R conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC610659-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF660R conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC610659-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF660R conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC680658-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF568 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC680658-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF568 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC680659-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF568 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC680659-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF568 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC470658-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF647 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC470658-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF647 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC470659-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF647 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC470659-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF647 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC430658-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF543 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/658) Antibody |
|||
| BNC430658-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF543 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC430659-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF543 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR1 / Flt-1(FLT1/659) Antibody |
|||
| BNC430659-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF543 conjugate, Concentration: 0.1mg/mL |
|||
VEGFR-1 Antibody |
|||
| 48347-100ul | SAB | 100ul | EUR 399.6 |
VEGFR-1 Antibody |
|||
| 48347-50ul | SAB | 50ul | EUR 286.8 |
Rat VEGFR-1/Flt1 ELISA Kit |
|||
| ERV0045 | Abclonal | 96Tests | EUR 625.2 |
Goat VEGFR-1/Flt1 ELISA Kit |
|||
| EGTV0045 | Abclonal | 96Tests | EUR 625.2 |
Mouse VEGFR-1/Flt1 ELISA Kit |
|||
| EMV0045 | Abclonal | 96Tests | EUR 625.2 |
Rabbit VEGFR-1/Flt1 ELISA Kit |
|||
| ERTV0045 | Abclonal | 96Tests | EUR 625.2 |